Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
Abstract Background To evaluate the predictive value of the lipiodol retention pattern for local progression of HCC with a complete response (CR) on CT according to mRECIST criteria after a first session of conventional chemoembolization (cTACE). Methods From January 2014 to May 2016 all consecutive...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Cancer Imaging |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40644-019-0260-2 |
id |
doaj-e6f54bac0d2a40daa668cce9cfa4c726 |
---|---|
record_format |
Article |
spelling |
doaj-e6f54bac0d2a40daa668cce9cfa4c7262021-04-02T18:02:32ZengBMCCancer Imaging1470-73302019-11-011911910.1186/s40644-019-0260-2Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete responseMarco Dioguardi Burgio0Riccardo Sartoris1Claudia Libotean2Magaly Zappa3Annie Sibert4Valérie Vilgrain5Maxime Ronot6Department of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineAbstract Background To evaluate the predictive value of the lipiodol retention pattern for local progression of HCC with a complete response (CR) on CT according to mRECIST criteria after a first session of conventional chemoembolization (cTACE). Methods From January 2014 to May 2016 all consecutive patients undergoing a first cTACE session for HCC were identified. Inclusion criteria were the presence of ≤3 HCCs and available pre- and post-cTACE CT. Tumor response was classified according to mRECIST criteria. The analysis focused on tumors with a CR. The lipiodol retention pattern in these tumors was classified as complete (C-Lip, covering the entire tumor volume), or incomplete (I-Lip). Local progression was defined as the reappearance of areas of enhancement on arterial-phase images with washout on portal/delayed phase images within 2 cm from treated tumors on follow-up CT. Results The final population included 50 patients with 82 HCCs. A total of 46 (56%) HCCs were classified with a CR, including 16 (35%) with I-Lip, and 30 (65%) with C-Lip. After a median follow-up of 14 months (3.2–35.9 months), 15/16 (94%) and 10/30 (30%) of I-Lip and C-Lip HCCs showed local progression on CT, respectively (p < 0.001), with no significant difference in the time to progression (mean 11.1 ± 2 vs. 13.4 ± 3 months for I-Lip and C-Lip, respectively p = 0.51). Conclusions HCCs with incomplete lipiodol retention after a first cTACE session have a high risk of local progression even when there is a CR according to mRECIST, and should be considered to be incompletely treated.http://link.springer.com/article/10.1186/s40644-019-0260-2Carcinoma, hepatocellularEthiodized oilChemoembolization, therapeutic |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marco Dioguardi Burgio Riccardo Sartoris Claudia Libotean Magaly Zappa Annie Sibert Valérie Vilgrain Maxime Ronot |
spellingShingle |
Marco Dioguardi Burgio Riccardo Sartoris Claudia Libotean Magaly Zappa Annie Sibert Valérie Vilgrain Maxime Ronot Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response Cancer Imaging Carcinoma, hepatocellular Ethiodized oil Chemoembolization, therapeutic |
author_facet |
Marco Dioguardi Burgio Riccardo Sartoris Claudia Libotean Magaly Zappa Annie Sibert Valérie Vilgrain Maxime Ronot |
author_sort |
Marco Dioguardi Burgio |
title |
Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response |
title_short |
Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response |
title_full |
Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response |
title_fullStr |
Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response |
title_full_unstemmed |
Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response |
title_sort |
lipiodol retention pattern after tace for hcc is a predictor for local progression in lesions with complete response |
publisher |
BMC |
series |
Cancer Imaging |
issn |
1470-7330 |
publishDate |
2019-11-01 |
description |
Abstract Background To evaluate the predictive value of the lipiodol retention pattern for local progression of HCC with a complete response (CR) on CT according to mRECIST criteria after a first session of conventional chemoembolization (cTACE). Methods From January 2014 to May 2016 all consecutive patients undergoing a first cTACE session for HCC were identified. Inclusion criteria were the presence of ≤3 HCCs and available pre- and post-cTACE CT. Tumor response was classified according to mRECIST criteria. The analysis focused on tumors with a CR. The lipiodol retention pattern in these tumors was classified as complete (C-Lip, covering the entire tumor volume), or incomplete (I-Lip). Local progression was defined as the reappearance of areas of enhancement on arterial-phase images with washout on portal/delayed phase images within 2 cm from treated tumors on follow-up CT. Results The final population included 50 patients with 82 HCCs. A total of 46 (56%) HCCs were classified with a CR, including 16 (35%) with I-Lip, and 30 (65%) with C-Lip. After a median follow-up of 14 months (3.2–35.9 months), 15/16 (94%) and 10/30 (30%) of I-Lip and C-Lip HCCs showed local progression on CT, respectively (p < 0.001), with no significant difference in the time to progression (mean 11.1 ± 2 vs. 13.4 ± 3 months for I-Lip and C-Lip, respectively p = 0.51). Conclusions HCCs with incomplete lipiodol retention after a first cTACE session have a high risk of local progression even when there is a CR according to mRECIST, and should be considered to be incompletely treated. |
topic |
Carcinoma, hepatocellular Ethiodized oil Chemoembolization, therapeutic |
url |
http://link.springer.com/article/10.1186/s40644-019-0260-2 |
work_keys_str_mv |
AT marcodioguardiburgio lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse AT riccardosartoris lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse AT claudialibotean lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse AT magalyzappa lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse AT anniesibert lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse AT valerievilgrain lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse AT maximeronot lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse |
_version_ |
1721552692024705024 |